* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected
to show no change in quarterly revenue when it reports
results on February 22 (estimated).
*
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 59 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Molecular
Transport Inc. is $1.25, above its last closing price
of $0.53.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.63 -0.65 -0.65 Met -0.5
Jun. 30 2022 -0.85 -0.78 -0.93 Missed -19.7
Mar. 31 2022 -0.74 -0.75 -1.10 Missed -46.2
Dec. 31 2021 -0.66 -0.66 -0.78 Missed -17.6
Sep. -0.61 -0.62 -0.68 Missed -9.7
30 2021
Jun. 30 2021 -0.59 -0.60 -0.62 Missed -3.3
Mar. 31 2021 -0.75 -0.75 -0.58 Beat 22.7
Dec. 31 2020 -0.51 -0.47 -0.38 Beat 20
This summary was machine generated February 20 at 11:13 GMT.
All figures in US dollars unless otherwise stated